rolapitant: Clinical Trials

3 trials of rolapitant, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 3 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 13Completed 3

Follow rolapitant: new trials by email Literature Review of rolapitant trials Research Report on rolapitant

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
An Open Label, Single Dose, Three Part Study to Assess the Effects of Rolapitant (2 mg/mL IV Solution) on the Pharmacokinetics of Digoxin; Sulfasalazine; and the Cooperstown Cocktail (Midazolam, Omeprazole, Warfarin, Caffeine, and Dextromethorphan in Healthy Subjects
Rolapitant, Digoxin, Sulfasalazine - Chemotherapy-induced Nausea and Vomiting
Phase 1CompletedTesaro, Inc.1022015-05-012015-08-25
A Phase 1, 2-Part, Single Ascending Dose Assessment of the Safety, Tolerability, and Pharmacokinetics of Rolapitant Intravenous in Healthy Volunteers
Rolapitant - Chemotherapy-induced Nausea and Vomiting
Phase 1CompletedTesaro, Inc.1002015-01-012015-08-25
An Open-Label, Randomized, Pivotal, Bioequivalence Study of Oral and Intravenous Rolapitant
Rolapitant - Oral, Rolapitant - IV - Chemotherapy-induced Nausea and Vomiting
Phase 1CompletedTesaro, Inc.1382014-09-012015-08-25

Conditions studied

Vomiting (3)

Sponsors

Tesaro, Inc. (3)

Countries

United States (3)

Top investigators

Dennis Vargo, MD (3)